These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34575411)

  • 1. Gene Expression and Protein Abundance of Hepatic Drug Metabolizing Enzymes in Liver Pathology.
    Drozdzik M; Lapczuk-Romanska J; Wenzel C; Szelag-Pieniek S; Post M; Skalski Ł; Kurzawski M; Oswald S
    Pharmaceutics; 2021 Aug; 13(9):. PubMed ID: 34575411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Abundance of Drug Metabolizing Enzymes in Human Hepatitis C Livers.
    Drozdzik M; Lapczuk-Romanska J; Wenzel C; Skalski L; Szeląg-Pieniek S; Post M; Parus A; Syczewska M; Kurzawski M; Oswald S
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reference liver-CYP450 and UGT enzymes in healthy donor and metastatic livers: the impact of genotype.
    Kurzawski M; Szeląg-Pieniek S; Łapczuk-Romańska J; Wrzesiński M; Oswald S; Droździk M
    Pharmacol Rep; 2022 Feb; 74(1):204-215. PubMed ID: 34741761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Traditional Herbal Formulas to as Treatments for Musculoskeletal Disorders: Their Inhibitory Effects on the Activities of Human Microsomal Cytochrome P450s and UDP-glucuronosyltransferases.
    Jin SE; Seo CS; Shin HK; Ha H
    Pharmacogn Mag; 2016; 12(48):241-252. PubMed ID: 27867264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry-based targeted proteomics method for the quantification of clinically relevant drug metabolizing enzymes in human specimens.
    Wenzel C; Drozdzik M; Oswald S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1180():122891. PubMed ID: 34390906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Abundance of Clinically Relevant Drug-Metabolizing Enzymes in the Human Liver and Intestine: A Comparative Analysis in Paired Tissue Specimens.
    Drozdzik M; Busch D; Lapczuk J; Müller J; Ostrowski M; Kurzawski M; Oswald S
    Clin Pharmacol Ther; 2018 Sep; 104(3):515-524. PubMed ID: 29205295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Herbal Formulas Bojungikgi-tang and Palmijihwang-hwan on Inflammation in RAW 264.7 Cells and the Activities of Drug-Metabolizing Enzymes in Human Hepatic Microsomes.
    Jin SE; Ha H; Shin HK
    J Med Food; 2018 Nov; 21(11):1173-1187. PubMed ID: 30457473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abundance of Phase 1 and 2 Drug-Metabolizing Enzymes in Alcoholic and Hepatitis C Cirrhotic Livers: A Quantitative Targeted Proteomics Study.
    Prasad B; Bhatt DK; Johnson K; Chapa R; Chu X; Salphati L; Xiao G; Lee C; Hop CECA; Mathias A; Lai Y; Liao M; Humphreys WG; Kumer SC; Unadkat JD
    Drug Metab Dispos; 2018 Jul; 46(7):943-952. PubMed ID: 29695616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic drug-metabolizing enzymes and drug transporters in Wilson's disease patients with liver failure.
    Szeląg-Pieniek S; Oswald S; Post M; Łapczuk-Romańska J; Droździk M; Kurzawski M
    Pharmacol Rep; 2021 Oct; 73(5):1427-1438. PubMed ID: 34117631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory potential of three Yin-tonification herbal formulas on the activities of human major cytochrome P450 and UDP- glucuronosyltransferases isozymes in vitro.
    Seong Eun J; Hyeun-Kyoo S; Hyekyung H
    J Tradit Chin Med; 2018 Aug; 38(4):511-522. PubMed ID: 32186076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics.
    Gröer C; Busch D; Patrzyk M; Beyer K; Busemann A; Heidecke CD; Drozdzik M; Siegmund W; Oswald S
    J Pharm Biomed Anal; 2014 Nov; 100():393-401. PubMed ID: 25218440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidation of individual cytochrome P450 enzymes involved in the metabolism of clozapine.
    Fang J; Coutts RT; McKenna KF; Baker GB
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):592-9. PubMed ID: 9840430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450-mediated metabolism of triclosan attenuates its cytotoxicity in hepatic cells.
    Wu Y; Chitranshi P; Loukotková L; Gamboa da Costa G; Beland FA; Zhang J; Fang JL
    Arch Toxicol; 2017 Jun; 91(6):2405-2423. PubMed ID: 27896399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory Effect of AB-PINACA, Indazole Carboxamide Synthetic Cannabinoid, on Human Major Drug-Metabolizing Enzymes and Transporters.
    Park EJ; Park R; Jeon JH; Cho YY; Lee JY; Kang HC; Song IS; Lee HS
    Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33138123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics.
    Achour B; Russell MR; Barber J; Rostami-Hodjegan A
    Drug Metab Dispos; 2014 Apr; 42(4):500-10. PubMed ID: 24408517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Herb-Drug Interaction of Synacinn™ and Individual Biomarker through Cytochrome 450 Inhibition Assay.
    Ab Rahman NS; Abd Majid FA; Abd Wahid ME; Zainudin AN; Zainol SN; Ismail HF; Wong TS; Tiwari NK; Giri S; Bhargava V
    Drug Metab Lett; 2018; 12(1):62-67. PubMed ID: 29542427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplex and Label-Free Relative Quantification Approach for Studying Protein Abundance of Drug Metabolizing Enzymes in Human Liver Microsomes Using SWATH-MS.
    Jamwal R; Barlock BJ; Adusumalli S; Ogasawara K; Simons BL; Akhlaghi F
    J Proteome Res; 2017 Nov; 16(11):4134-4143. PubMed ID: 28944677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of an ethanol extract of Descurainia sophia seeds on Phase I and II drug metabolizing enzymes and P-glycoprotein activity in vitro.
    Yi JM; Kim YA; Lee YJ; Bang OS; Kim NS
    BMC Complement Altern Med; 2015 Dec; 15():441. PubMed ID: 26683337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases by MAM-2201 in human liver microsomes.
    Kong TY; Kim JH; Kwon SS; Cheong JC; Kim HS; In MK; Lee HS
    Arch Pharm Res; 2017 Jun; 40(6):727-735. PubMed ID: 28484907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
    Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
    Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.